Portfolio News
- July 12, 2010 - Dow Jones Investment BankerTHE REMEDY: Amarin's Lessons In Crisis Management
- July 08, 2010 Infinity and Intellikine Enter Agreement to Develop Oral Therapies Targeting PI3 Kinase Delta, Gamma
- June 30, 2010 Vicept Therapeutics Secures $10 Million to Complete Series A Funding; Company to Develop Lead Product for Rosacea and Other Topical Agents for the Treatment of Skin Disorders
- June 23, 2010 Anthera Enrolls First Patients in Pivotal Varespladib Phase 3 Clinical Study
- June 16, 2010 KXEN Secures $8 Million in Series D Funding
- June 04, 2010 Ascenta Therapeutics Licenses Cancer Drug Candidates to Sanofi-Aventis
- June 04, 2010 - The Wall Street Journal OnlineThe $100M Revenue Club: Cortina Systems, Powered By Intel
- June 01, 2010 HelloSoft Presents TriPhone, a $100 4G Android-based Trimode Reference Handset
- May 31, 2010 CrestaTech Extends CrestaTV Universal Receiver to Support All PC Processors
- May 26, 2010 Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc.
- May 25, 2010 Cortina Takes PON Integration to Next Level with Voice and Switching
- May 19, 2010 Trius Therapeutics Awarded U.S. Department of Defense Contract to Develop Novel Antibiotics
- May 19, 2010 Movetis Starts Phase III Clinical Trial with Prucalopride in Patients with Opioid-Induced Constipation (OIC)
- May 18, 2010 PregLem Announces Positive Phase III Results for Esmyatm as an Effective Treatment for Uterine Fibroids
- May 17, 2010 Anti-Pseudomonas Activity of KaloBios'/sanofi pasteur's KB001 May Prevent Serious Lung Infections and Limit Damaging Inflammation